Entering text into the input field will update the search result below

Genetic Tech up 95% on U.S. launch of breast cancer test

Jan. 07, 2020 2:58 PM ETGenetic Technologies Limited (GENE) StockGENEBy: Douglas W. House, SA News Editor
  • Thinly traded nano cap Genetic Technologies Limited (GENE +94.7%) rockets up on a whopping 333x surge in volume in reaction to the impending U.S. commercial launch of its GeneType for Breast Cancer test designed to assess breast cancer risk in patients at least 35 years old.
  • It plans to commence a limited release across 20 centers in eight states this quarter followed by full launch in Q2.

Recommended For You

More Trending News

About GENE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GENE--
Genetic Technologies Limited